TY - JOUR
T1 - Relative ADC and location differ between posterior fossa pilocytic astrocytomas with and without gangliocytic differentiation
AU - Harreld, J. H.
AU - Hwang, S. N.
AU - Qaddoumi, I.
AU - Tatevossian, R. G.
AU - Li, X.
AU - Dalton, J.
AU - Haupfear, K.
AU - Li, Y.
AU - Ellison, D. W.
N1 - Funding Information:
This work was supported, in part, by grant No. CA21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities.
PY - 2016/12
Y1 - 2016/12
N2 - BACKGROUND AND PURPOSE: Pilocytic astrocytomas, the most common posterior fossa tumors in children, are characterized by KIAA1549-BRAF fusions and shows excellent 5-year survival rates. Pilocytic astrocytoma with gangliocytic differentiation, a recently defined pilocytic astrocytoma variant that includes glial and neuronal elements similar to a ganglioglioma, may be distinguished from a classic ganglioglioma by molecular, radiologic, and histopathologic features. This study investigated whether imaging could distinguish posterior fossa pilocytic astrocytoma with and without gangliocytic differentiation. MATERIALS AND METHODS: Preoperative MRIs (± CTs) of 41 children (age range, 7 months to 15 years; mean age, 7.3 ± 3.7 years; 58.5% male) with pilocytic astrocytoma with gangliocytic differentiation (n=7) or pilocytic astrocytoma (n=34) were evaluated; differences in tumor location, morphology, and minimum relative ADC between tumor types were compared (Wilcoxon rank sum test, Fisher exact test). Histopathology and BRAF fusion/mutation status were reviewed. Associations of progression-free survival with diagnosis, imaging features, and BRAF status were examined by Cox proportional hazards models. RESULTS: Pilocytic astrocytoma with gangliocytic differentiation appeared similar to pilocytic astrocytoma but had lower minimum relative ADC (mean, 1.01± 0.17 compared with 2.01 ± 0.38 for pilocytic astrocytoma; P= .0005) and was more commonly located within midline structures (P = .0034). BRAF status was similar for both groups. Non-Total resection (hazard ratio, 52.64; P= .0002), pilocytic astrocytoma with gangliocytic differentiation diagnosis (hazard ratio, 4.66; P = .0104), and midline involvement (hazard ratio, 3.32; P = .0433) were associated with shorter progression-free survival. CONCLUSIONS: Minimum relative ADC and tumor location may be useful adjuncts to histopathology in differentiating pilocytic astrocytoma with gangliocytic differentiation from pilocytic astrocytoma. Shorter progression-free survival in pilocytic astrocytoma with gangliocytic differentiation is likely due to a propensity for involvement of midline structures and poor resectability.
AB - BACKGROUND AND PURPOSE: Pilocytic astrocytomas, the most common posterior fossa tumors in children, are characterized by KIAA1549-BRAF fusions and shows excellent 5-year survival rates. Pilocytic astrocytoma with gangliocytic differentiation, a recently defined pilocytic astrocytoma variant that includes glial and neuronal elements similar to a ganglioglioma, may be distinguished from a classic ganglioglioma by molecular, radiologic, and histopathologic features. This study investigated whether imaging could distinguish posterior fossa pilocytic astrocytoma with and without gangliocytic differentiation. MATERIALS AND METHODS: Preoperative MRIs (± CTs) of 41 children (age range, 7 months to 15 years; mean age, 7.3 ± 3.7 years; 58.5% male) with pilocytic astrocytoma with gangliocytic differentiation (n=7) or pilocytic astrocytoma (n=34) were evaluated; differences in tumor location, morphology, and minimum relative ADC between tumor types were compared (Wilcoxon rank sum test, Fisher exact test). Histopathology and BRAF fusion/mutation status were reviewed. Associations of progression-free survival with diagnosis, imaging features, and BRAF status were examined by Cox proportional hazards models. RESULTS: Pilocytic astrocytoma with gangliocytic differentiation appeared similar to pilocytic astrocytoma but had lower minimum relative ADC (mean, 1.01± 0.17 compared with 2.01 ± 0.38 for pilocytic astrocytoma; P= .0005) and was more commonly located within midline structures (P = .0034). BRAF status was similar for both groups. Non-Total resection (hazard ratio, 52.64; P= .0002), pilocytic astrocytoma with gangliocytic differentiation diagnosis (hazard ratio, 4.66; P = .0104), and midline involvement (hazard ratio, 3.32; P = .0433) were associated with shorter progression-free survival. CONCLUSIONS: Minimum relative ADC and tumor location may be useful adjuncts to histopathology in differentiating pilocytic astrocytoma with gangliocytic differentiation from pilocytic astrocytoma. Shorter progression-free survival in pilocytic astrocytoma with gangliocytic differentiation is likely due to a propensity for involvement of midline structures and poor resectability.
UR - http://www.scopus.com/inward/record.url?scp=85006454858&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85006454858&partnerID=8YFLogxK
U2 - 10.3174/ajnr.A4892
DO - 10.3174/ajnr.A4892
M3 - Article
C2 - 27469209
AN - SCOPUS:85006454858
SN - 0195-6108
VL - 37
SP - 2370
EP - 2375
JO - American Journal of Neuroradiology
JF - American Journal of Neuroradiology
IS - 12
ER -